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Abstract 
 
Aims: Study of  local use of Karpoor ghrita and  Povidone- Iodine  in Sadyovrana. Objectives: 1.To study 
comparative effect of karpoor ghrita and Povidone- Iodine in sadyovrana. 2. To study assess the effect of ‘karpoor 
ghrita’ in minimizing infections after injury. 3. To study compare the days for wound healing for both drugs. As 
the reference has been quoted from Sadyo Vrana Chikitsadhyaya, the formulation of this medicine is to be used 
only in Sadyo Vranas i.e. Shuddha Vrana. Methods: In this study 60 Diagnosed Patients Of  sadyovrana  were Tak-
en From O.P.D And I.P.D Of Shalyatantra Department Of  hospital. Clinical was Conducted.Computer Generated 
Random Number Table Were Used For Clinical Trial.  Trial group 30 Patients Of  karpoor ghrita dressing and con-
trol group 30 patients of povidone- iodine dressing  were Enrolled Under Following Groups Irrespective Of Sex 
And Religion. Observations and results: In this clinical study it is seen that, Clinical parameters like Vedana,, Var-
na, Akruti, Gandha, were significantly reduced after treatment in Trial group than in Control Group and srava 
showed equal results. Number of Days required for ropan were less in Trial group than that in Control Group. After 
testing the effectiveness of Karpoorghrita treatment against the Standard betadine Treatment, results showed that 
The Karpoorghrita treatment has better results than the Standard betadine in Sadyovrana Patients. 
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Introduction 
 SADYO VRANAs mostly occur due to accidental 
injuries. As we see in today’s world the number of 
major & minor injuries taking place has increased.(1) 
 Sushruta Samhita has given superior position to 
Vrana. Sutrasthan of this samhita shows description of 
the Vrana in most of the chapters and Chikitsa Sthana 
begins with Chapter for Vrana(2). Shalyatantra brings 
out very clearly that vrana is the most significant 
surgical entity, its knowledge and effective 
management for a surgeon is the basic skill required. 
 Surgery and wound go hand in hand, the wound 
may be due to some kind of trauma or be it by the 
surgeon’s knife. In todays fast paced life safety is 
taking a back seat leading to many kind of injuries 
especially common are abrasions and lacerations 
mostly seen in road traffic accidents. Sadyovrana is an 
entity we commonly come across, it is associated with 
a lot of pain and caused due to external trauma. 
  The mechanism of wound healing depends on 
certain factors which have centred mainly on 
prevention of vitamins, trace element and protein 
deficiencies that delay wound healing. There are some 
chemical agents that promote wound healing, but they 
are scarce and requiring various desirable effects and 
needs of healing feature for betterment. Since time 
immemorial, its been an ongoing process to search 
better remedy to minimize and overcome drawbacks of 
previous ones. 
The aim of treating a wound is to either shorten 
the time required for healing or to minimize the 
undesired consequences. There are many factors 
responsible to make healing process delayed like dead 
tissues, insufficient blood supply, protein deficiency, 
diseases like diabetes mellitus, tuberculosis etc(3). In 
case of delayed healing, it is more likely to be local than 
general which clarifies the magnitude of the problem of 
study. Many investigations and experiments have been 
carried out in medical science to understand the 
phenomenon of wound healing. Analgesics, antibiotics 
and antiseptics like Povidone iodine, Silver 
sulphadiazine etc .are in use for the treatment of 
wounds.These treatment modalities still have their own 
limitations and side effects. Attention is directed to 
discover an agent which will accelerate wound healing 
with less side effects. Modern day treatment of wound 
does not comprise of a single drug offering both 
properties of cleaning and healing of wound by the 
same drug. That is why the search is still on to find out 
a drug which can fulfil the optimal requirement. 
Ayurveda is an applied science and time tested 
health system with vast scope of trails to prove certain 
principles as well as therapeutic effects of medicines. 
SADYO VRANA is in Shuddha state for 7 days so; 
if these Vranas are treated within 7 days their chances 
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of getting infected are reduced.(4).Karpoorghrita 
mentioned in Sadyovrana chikitsa was chosen as 
according to its reference mentioned in Sadyovrana it 
possesses healing property vrana ropan(5). Povidone 
iodine is an excellent drug as far as cleansing is 
concerned but it to some extent interferes in healing of 
wound. To compare and understand there effects on 
wound Karpoorghrita and povidone iodine were chosen. 
Studies reveal that it is difficult to achieve 
complete aim of wound management with single agent 
hence there is need to find out a single effective 
formulation which possesses vrana ropana property 
without wound infection. 
There lies an extensive scope of research in 
ayurveda which would prove beneficial to the society. It 
would be cost effective and with less complications. 
Hence various formulations need to be revived, tested 
and used in treating wounds. An attempt to revive an 
important preparation is done here. 
 
Materials and Methods 
A] Conceptual study: Literary study of 
karpoorghrita and Vrana was done. 
 
B] Cllinical trial: 
Selection  of  patient- 
For  present  clinical  study  60 patients  of  
sadyo Vrana were  selected  from    O.P.D. and  I.P.D. 
department of  Shalyatantra of hospital. These  patient  
were  selected  irrespective  of  their  age,  sex,  religion,  
educational,  marital,  and  socio  economic  status.  
Detailed  history  of  all  patient  were  obtained  as  per  
prepared  proforma . Routine investigations were done 
like haemogram, urine routine, B.S.L.random, .Random  
sampling  of  patients was  done. Informed written 
consentof each  patient  taken  for   the study. Then 
clinical  trial was  conducted. 
Grouping of patient-In  present  clinical  study,  
two  groups  were  doneasfollows. In each group 30 
patients of sadyo Vrana were selected  for  study. In 
each group wound cleaned with normal saline. 
 Group A (Trial Group) – Vrana Karma done with 
Karpoorghrita. 
 Group B (Control Group) -Vrana Karma done 
with Povidone-Iodine. 
 
Criteria for inclusion 
 Ghrishta Vrana(Abrasions) 
 Kshataja Vrana(laceration) 
  Due to trauma &accident . 
 
Criteria  for  exclusion 
 Chhinna Vrana,  
 Bhinna Vrana,  
 Viddha  Vrana,  
 PichchitaVrana 
 
Withdrawal  criteria- 
 Patient is not responding to the treatment and 
aggravation of symptoms within 7 days. 
 Patient refuses to continue the treatment. 
 
Drug Review 
Ayurvedic Review 
Karpoorghrita : (6) 
 
 
Preparation of shatadhauta ghrita :(7) 
 Washing goghrita again and again for a total of 
100 times with water gives shatadhauta ghrita which 
possess the properties of allievating pitta, daha and is 
vrana ropana. 
 
Materials : 
 Copper vessels  - pan, agitator 
 Goghrita (cows ghee) 
 Distilled water 
 
Method : 
 Copper vessels were cleaned properly and and 
thoroughly rinsed with water. 
 Desired amount of goghrita was taken in a copper 
pan. 
 Two times of ghrita amount of water was added 
to it. 
 Mardan (agitation) of goghrita and water was 
done with the help of manual copper agitator 
(vessel) for 5 to 8 minutes. 
 The contents were allowed to settle. The water 
was decanted carefully to avoid loss of ghrita. 
 Again little amount of water was added to the 
previously washed goghrita and the same process 
of mardan was done. 
 This process was done one hundred times to 
obtain shatadhauta ghrita. 
 The obtained sample was used futher  asa base to 
prepare Karpoorghrita.  
 
Properties of Shatadhauta ghrita : 
 Has better consistent and viscous than ghirta and 
hence useful in topical application. 
 Reduction in particle size facilitates increased 
absorption through skin(8). 
 Copper content makes it anti-inflammatory. 
 
Preparation of drug karpoorghrita : 
            It is prepared by Malhar kalpana (9). 
 
Materials : 
 Upadhan dravya (Base) : Shata dhauta ghrita -
60gm 
 Adhan dravya (main ingredient) : karpoor -10gm 
 A pan 
 
 
No. Ingredients/ 
Botanical Name 
Part used Quantity 
01. Karpoor 
Cinnamomum 
camphora (L.) J. 
Presl.  
Resin 10 g. 
02. shatdhauta ghrita Ghee 60 g. 
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Method : 
 The preparation was done according to tirturation 
(peshana) method for malhar kalpana. 
 essel used was cleaned and rinsed thoroughly 
with water. 
 10 gm shatadhauta ghrita was taken and and 
equal quantity of fine standardized karpoor 
churna sieved an pharmacy was added to it. 
 Shatadhuta ghrita was added in increasing order 
till a mixture free of grittiness was obtained. 
 Tirturation (peshana) of the above mixture was 
carried out till a homogeneous mixture was 
obtained with good consistency. 
 The sample of karpoorghrita malhar thus 
obtained was stored. 
 The   prepared  malhar stored  in  the  sterilized  
bottles  and  used  for  clinical  trial  on  the  
patients. Standerdisation of final product  done. 
 
Raspanchaka of dravyas used in Karpoorghrita(10): 
 
 
 
Modern Review: 
Povidine-Iodine(11) 
Generic name-   Povidone  -  iodine 
IUPAC name- 
2-Pyrrolidinone, 1-ethenyl-, homopolymer, compd. with 
iodine. 
Chemical formula- 
 
 
 
Properties  and  effects 
 Iodine  is  as  an  effective  and  useful  germicide.   
It  is  very  effective  against  variety  of  
microorganisms   such  as  viruses,  bacteria,  protozoa,  
yeast and  fungi.  
However  its  frequent  use  is  contraindicated  
because  its  insolubility  and  its  staining  and  
irritating  properties.  Many  of these  undesirable  
qualities  of  iodine  could  be eliminated  by  
No. Ingredient Rasa/ Guna/ Virya/ Vipaka/ 
Dosha Karma 
01. Karpoor Tikta, Katu, Madhur rasa, Laghu, 
Tikshna guna, Shita virya, Katu 
vipaka and  Tridoshahara 
02. Shatdhaut 
ghrita 
Madhur rasa, Snigdha, Guru, 
Shita guna, Shita virya, Madhura 
vipaka, Tridoshahara 
combining   it  with  polyvinyl  pyrrolidone  (povidone).  
This  organic  polymer  is  water  soluble,  when  it  is  
combined  with iodine.   
A complex is  formed  in  which  iodine’s  toxic  
effects  are  lost  without  its  bacterial  activity being  
affected.  This  complex,  povidone,  iodine  (Polyvinyl  
pyrroiodone  iodine)  abbreviated as  pvp-1has been  
used  effectively  as  a  surface  disinfectant.     
Povidone  is  an  effective  germicide.  High  dilutions  
are  active  in  destroying  organisms  within  15  
seconds.  Color  loss  is  accompanied  by  the  
weakening  germicidal   activity. 
 
Assessment Criteria 
 Subjective parameters taken and the Grading 
pattern of the parameters is as follows 
 
 
 
Clinical End-points: 
Primary End-point: 7 days in which suddha avastha of 
sadyo vrana maintained and clinical symptoms reduced 
completely if wound care taken properly. 
 
Secondary End-point: Total days for Ropan was 
considered as the secondary end-point for the study. 
 
Vedana:  
 The vedana will be assessed by visual 
analogue scale. A 10 cm visual analouge scale of pain 
will be used for measurement. 
Akruti  
Grade I < 5 cm 
Grade II 5-10 cm 
Grade III 10-20 cms 
Varna  
No Granulation of tissue 0 
Granulation of tissue    
(Ruhyaman vrana ) 
1 
Pale base of wound. 2 
Yellowish slough at base & edges. 3 
Gandha  
No smell 0 
Foul smell 1 
Srava  
No discharge 0 
Bloody discharge  1 
Serous discharge  2 
Purulent discharge 3 
Heavy Purulent discharge 4 
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Based on these criteria, the percentage relief in both the 
groups was as follows: 
 
 
Graph 1: Showing the percentage of relief in the 
parameters in both the groups as below: 
 
 It is clear from the above graph that the % of 
relieved patients is higher in the Trial group for Vedana, 
Akruti, Varna, Gandha symptoms. For Srava, the % 
relief for trial and control is same. Thus, it can be 
concluded that the trial group treatment is more 
effective than the control group treatment as far as relief 
is concerned. 
% relieved Trial Control 
Vedana 86.66 73.33 
Srava 80 80 
Akruti 86.66 80 
Varna 86.66 80 
Gandha 80 53.33 
Days required for Ropan: 
 The total number of days for ropan required for 
patients in Trial vs Control group shows us the efficacy 
of the treatment in trial group as below: 
 
 
Graph 2: Showing the Time taken for the ropana in 
both the groups as below: 
 
 It can be concluded from the graph that 80% 
patients from the Trial group needed only upto 10 days 
for Ropan, while only 56.6% of the patients from 
control group fall under this class.Also, effectively, the 
% of patients from trial group that needed 11 to 15 days 
for Ropan are subsequently lesser than their 
counterparts in the control group. 
  Trial group Control group 
Total 
days for 
ropan 
Number 
of 
patients 
% of 
patient 
Number 
of 
patients 
% of 
patients 
6 to 10 24 80 17 56.66 
11 to 
15 6 20 13 43.33 
16 to 
20 0 0 0 0 
Total 30 100 30 100 
Observations and Results 
Efficacy testing of the treatment was performed using Two-way ANOVA for repeated measures. 
 
Table 1 Showing the TWO-Way ANOVA Results for the various parameters taken : 
 
Measure Correction 
Type III  
Sum of Squares Df 
Mean 
Square F P-value 
Vedana Greenhouse-
Geisser 
3538.85 2.68 1316.85 571.87 0.03 
Srava Greenhouse-
Geisser 
29.28 2.12 13.80 24.78 0.049 
Akruti Greenhouse-
Geisser 
6.13 1.87 3.27 10.42 <0.005 
Varna Greenhouse-
Geisser 
95.09 3.59 26.47 112.61 <0.005 
Gandha Greenhouse-
Geisser 
6.68 2.69 2.484 15.54 <0.005 
Significance Threshold: 
P<0.05: P-values less than 0.05 will be considered to be significant 
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Discussion 
 It is clear from above that % of relieved patients 
is higher in the trial group for each symptom. Thus it 
can be concluded that the trial treatment is more 
effective than the Control Group as far as relief is 
concerned. 
Vedana : 
 After treating the patients from trial group with 
karpoor ghrita, assessment of  Vedana shows p- 
value=0.03. Thus we accept alternate hypothesis. So it 
can be said that Vedana after treatment with 
karpoorghrita was significantly reduced than Vedana 
when treated with betadine treatment. 
 Vedana may be reduced due to soothing effect of 
shatadhuta ghrita. 
 
Srava : 
 After treating the patients from trial group with 
Karpoorghrita, assessment of Srava shows p- 
value=0.049. Thus we accept null hyopthesis. So it can 
be said that Sravawith both karpoorghrita and betadine 
showed equal results aftertreatment.Sravamay have 
controlled due to Raktasthambhak, sheetaveerya, s 
irasankochak properties of content of the preparation. 
 
Varna: 
 After treating the patients from trial group 
withKarpoorghrita, assessment of Varna shows p- 
value=< 0.05. Thus we accept alternate hypothesis. : 
Karpoorghritatreatmentin patients of sadyovrana 
results in better granulation of varnathan the Betadine 
treatmentover the period of treatment. 
 
Akruti: 
 After treating the patients from trial group 
withKarpoorghrita, assessment of Akruti shows p- 
value=< 0.05. Thus we accept alternate hypothesis. So 
it can be said that Akruti after treatment with 
karpoorghrita was significantly reduced than Akruti 
with betadine treatment. 
 Akruti was controlled due to ropana andSandhan 
property of drug and helped wound contraction. 
 
Gandha : 
 After treating the patients from trial group with 
Karpoorghrita, assessment of Gandha shows p- 
value=< 0.05. Thus we accept alternate hypothesis 
thatKarpoorghritatreatmentin patients of sadyovrana 
results in less gandhaat the end of treatment than 
betadine. 
 
Days Required for ropan: 
 From the statistical analysis it can be concluded 
that 80% patients from Trial group needed only upto 6-
10 days of ropan, while only 56.66% of patients from 
control group fall under this class. Also 20% of patients 
from trial group that needed 11 to 15 days of ropan as 
opposed to 43.33% patients from control group and 
which is significantly more. 
 
Total Effect of Therapy 
 In this clinical study it is seen that, Clinical 
parameters like Vedana,, Varna, Akruti, Gandha, were 
significantly reduced after treatment in Trial group than 
in Control Group and srava showed equal results. 
 Number of Days required for ropan were less in 
Trial group than that in Control Group. 
 
Comparitive Study : 
 After testing the effectiveness of Karpoorghrita 
treatment against the Standard betadine Treatment, 
results showed that The Karpoorghrita treatment has 
better results than the Standard betadine in Sadyovrana 
Patients. 
 
Probable Mode of Action of The Drug in Trial 
Group-(12, 13) 
 Action of ropana may be due to Vrana prasadan 
karma of ghrita and are effective to its maximum 
content by way of letting the wound becomes heal. 
 Karpoorghrita has vrana ropan potential 
and therefore shows this effect. 
Vrana vedana may be reduced due to “eugenol” 
as it is analgesic, depresses the sensory nerves and is 
vedana sthapana. 
Karpoor contains antiseptic compound – “cineol 
and terpineol”, so is moderately antiseptic helped in 
prevent doshpak of the Vrana. 
Vrana i.e granulation of wound may be 
attributed to the property of Karpoor that it stimulates 
local vessels thus increasing vascular supply required 
for healing. 
Cineol is a rubefacient hence increses dermal 
uptake of the drug. 
Karpoor belongs to the gana of sugandhi dravyas 
and possesses a pleasant odour since it contains 
“volatile oils” hence gandha may be absent at end of 
treatment. 
Shatadhauta ghrita has Vrana ropana property 
hence disinfection and akruti can be explained.(14) 
Hence, Trial group was seen to have significant 
results as the Control group. It means we can conclude 
that Vrana Karma with Karpoorghrita has significant 
results on Sadhyo Vrana as compared to Povidone-
Iodine. 
 
Conclusion  
1. In this clinical study it is seen that, Clinical 
parameters like Vedana, Varna, Akruti, Gandha 
were significantly reduced after treatment with 
Karpoorghrita  in Trial group than treatment 
with betadine (povidone iodine) in Control 
Group; whereas srava was seen to be equal with 
treatment of Kaproopghrita as well as betadine. 
2. Number of Days required for Ropana were  less 
in Trial group than that in Control Group. 
3. Hence the final conclusion that can be drawn is –
vranakarma in Sadhyo Vrana with Karpoorghrita 
is better than with povidone-Iodine. 
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